Q Fever News and Research

RSS

Dry cracked skin of eczema patients promotes 'atopic march'

Infants who develop eczema are more likely to develop food allergies, hay fever and asthma as they grow older, a progression known as the atopic march.

17 Jul 2019

FDA approves antibacterial drug to treat complicated urinary tract infections, intra-abdominal infections

The U.S. Food and Drug Administration has approved Recarbrio (imipenem, cilastatin and relebactam), an antibacterial drug product to treat adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI).

17 Jul 2019

Researchers find mechanism behind susceptibility to viral infections

A team of researchers from the SingHealth Duke-NUS Academic Medicine Centre's Viral Research and Experimental Medicine Centre found that immune cells undergoing stress and an altered metabolism are the reasons why some individuals become sick from viral infections while others do not, when exposed to the same virus.

16 Jul 2019

Puzzling paralysis affecting healthy children warns CDC

The Centers for Disease Control and Prevention (CDC) has warned that a series of rare and difficult to treat cases of paralysis are being seen in otherwise healthy children since 2018. This outbreak is 2018 may soon make a comeback in 2020 the organization warns doctors and paediatricians. The report was published in the CDC’s Vital Signs this week.

11 Jul 2019

Australia leads the world in childhood immunization coverage

Even as Australia reels under a deadly flu season, some solace may be found in the fact that almost 95% of of five-year-old Australian children are almost completely immunized against deadly childhood diseases, according to the latest report.

8 Jul 2019

Scientists identify mechanism that makes babies more likely than adults to die from sepsis

An immune mechanism that makes babies more likely than adults to die from sepsis has been identified by scientists affiliated with the Center for Research on Inflammatory Diseases in Ribeirão Preto, São Paulo State (Brazil).

4 Jul 2019

$FDA grants accelerated approval to new treatment for refractory multiple myeloma$

FDA grants accelerated approval to new treatment for refractory multiple myeloma

Today, the U.S. Food and Drug Administration granted accelerated approval to Xpovio (selinexor) tablets in combination with the corticosteroid dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma who have received at least four prior therapies and whose disease is resistant to several other forms of treatment, including at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody.

3 Jul 2019

Study investigates the influence of surgery, anesthesia on MS relapse risk

A recent Multiple Sclerosis Journal study that included data from 281 patients and 609 surgeries suggests post-operative MS relapse risk does not significantly differ from pre-operative relapse risk.

29 Jun 2019

Increasing awareness about visceral leishmaniasis could help reduce fatalities, disease transmission

Women in Indian states with endemic visceral leishmaniasis - also known as Kala Azar - should be encouraged to seek care for persistent fever without delay.

From PLOS ONE 28 Jun 2019

Higher levels of doublets in flow cytometry indicate tuberculosis or dengue fever

Sorting through individual immune cells is a handy way to see how the body responds to disease. For years, researchers around the world have used a technique called flow cytometry to separate different types of immune cells, such as T cells, B cells and monocytes.

26 Jun 2019

Nitrogen-rich diet reduces mosquitoes' ability to transmit Zika

Feed mosquitoes more nitrogen when they're young, and the adults are less likely to transmit the Zika virus, University of Florida scientists say. Now, researchers want to know why, and they're determined to discover how the findings can help further their research into the dangerous virus.

24 Jun 2019

NIH offers $377,971 grant to develop disposable HIV-1 viral load microchip

As of 2017, about 36.9 million people around the world were living with HIV-- 1 in 4 were unaware of their HIV status.

21 Jun 2019

Research opens door to better treatment for common cause of diarrhea

One of the most common causes of diarrhea worldwide – accounting for millions of cases and tens of thousands of deaths, mostly of small children – is the parasiteCryptosporidium.

20 Jun 2019

Many healthcare workers often care for patients while sick, study finds

Large numbers of healthcare workers risk transmitting respiratory viruses to patients and co-workers by attending work even when they have symptoms, according to a study published today in Infection Control & Hospital Epidemiology, the journal for the Society for Healthcare Epidemiology of America.

18 Jun 2019

Developing new immunotherapeutic treatments for emerging viral diseases

Emerging viral diseases is a term used to refer to diseases caused by pathogens such as the Ebola virus. Whilst vaccines can protect people against these diseases, there is an urgent need for treatment options after infection.

14 Jun 2019

Experimental antiviral drug cures mice infected with deadly tick-borne virus

Only a few cases of the newly discovered Bourbon virus have been reported, and two of them ended in death, partly because no specific treatments are available for the tick-borne illness.

14 Jun 2019

Ebola spread to Uganda could threaten international health

After smouldering in the Democratic Republic of Congo (DRC) for almost a year, killing near 1,000 people, the deadly Ebola virus crossed the border to Uganda in June 2019. This virus causes sudden high fever and sore throat, with severe weakness and muscle pain.

14 Jun 2019

New study suggests bacteria-loaded mosquitoes may halt spread of Dengue fever

Dengue fever stopped spreading in an Australian city, called Townsville, after an army of mosquitoes infected with the Wolbachia bacterium was released on it.

11 Jun 2019

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as "BR"), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies.

10 Jun 2019

War against mosquitoes saves lives and money in Sri Lanka

A large-scale drive against mosquitoes in Sri Lanka reduced the incidence of dengue fever and saved a lot of money as well, according to a study led by the New York University of Global Public Health.

6 Jun 2019